Clinical Trials Directory

Trials / Unknown

UnknownNCT02112968

A Prospective Safety and Effectiveness Study of a New High Repetition Rate Excimer Laser Using LASIK for the Correction of Ammetropia and Presbyopia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
97 (estimated)
Sponsor
Technolas Perfect Vision GmbH · Industry
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This clinical study has been planned to evaluate the safety and effectiveness of common treatment algorithms using 500 Hz laser repetition rate for the correction of Ammetropia and Presbyopia

Detailed description

This clinical study has been planned to evaluate the safety and effectiveness of the excimer laser treatment algorithms Proscan, Zyoptix and Supracor of the 500 Hz laser system for ametropia and/or presbyopia when performed on the cornea of virgin eyes.

Conditions

Interventions

TypeNameDescription
PROCEDUREProscanOne device (500 Hz Excimer Laser) with three interventions (Proscan, Zyoptix and Supracor as algorithms)
PROCEDUREZyoptixOne device (500 Hz Excimer Laser) with three interventions (Proscan, Zyoptix and Supracor as algorithms)
PROCEDURESupracorOne device (500 Hz Excimer Laser) with three interventions (Proscan, Zyoptix and Supracor as algorithms)

Timeline

Start date
2014-12-01
Primary completion
2016-02-01
Completion
2017-05-01
First posted
2014-04-14
Last updated
2014-11-20

Source: ClinicalTrials.gov record NCT02112968. Inclusion in this directory is not an endorsement.